Putnam

Listen now to the second episode of our podcast series with PM360 Magazine as we join Vynamic experts to discuss the critical early planning stage of product launches. In the episode, Ankit Patel, Ashley Stanley and Brian Stamm explore why starting preparations earlier than ever is essential, how to define adaptable launch scenarios, and the transformative role of technology in optimizing decision-making. Tune in here: https://lnkd.in/e2cQtfMb #PharmaLaunch #ProductStrategy #NavigateWithCertainty #Podcast

The U.S. vaccines landscape is evolving rapidly. Our latest white paper explores key trends and strategies for manufacturers to stay ahead in this dynamic market. Gain valuable insights to navigate challenges, optimize opportunities, and drive success in the vaccine industry. Download your copy today: https://lnkd.in/efnjATC5 #Vaccines #LifeSciences #HealthcareInnovation #Putnam #PharmaInsights

As the year comes to a close, we’re filled with gratitude for the people who make it all happen—our incredible team. Thank you for your passion, hard work, and unwavering commitment. Here’s to another year of growth, collaboration, and success! #ThankYouTeam #YearEndReflection #Gratitude

In a recent podcast episode with PM360 Magazine, Gan Hong Tan, Partner, was joined by host Katie Lineberry, Account Director at Inizio Advisory and Liza Pliss, Vice President at Research Partnership to discuss the complexities of product launch planning. Here’s a peek into the episode from Gan. Tune in now as they explore the critical pre-launch phase, sharing insights on developing data-driven strategies to optimize your market approach and ensure a successful product launch. Listen here: https://lnkd.in/dMCezswW #DataInnovation #AIinPharma #AI #NavigateWithCertainty 

Innovation in data and AI is revolutionizing decision-making in the pharmaceutical industry, but knowing where to begin can be challenging. In our latest insight, Aman Singh, Director, Data Products & Platforms at Putnam, highlights how pharma leaders can utilize new cutting-edge tools to tackle key challenges and get deeper, actionable insights. Explore how aligning the right technology with specific challenges can unlock the full power of data and AI. Read the piece here: https://lnkd.in/ebws5wZt #DataInnovation #AIinPharma #AI #NavigateWithCertainty

The 2024 ASH Annual Meeting delivered a wealth of groundbreaking hematology advancements, but navigating the large volume of data and discussions can be overwhelming. That’s where ClarityNav, part of the InizioNavigator suite, comes in. We leveraged our proprietary AI-driven tool to analyze digital discussions, distill key trends, and provide rapid, objective insights. Learn more about these insights and key trends, and see how we turned complexity into clarity here: https://lnkd.in/gRyTDfns Michael Harvey, PhD, Lori Klein, PharmD, Joseph Feingold #ASH2024 #HematologyInsights #AI #BiopharmaStrategy #NavigateWithCertainty

How has the US vaccine landscape evolved since 2020? Due to the pandemic, technological breakthroughs, and changing priorities, this space has seen profound transformations. In our latest white paper, we explore these shifts, uncover emerging trends, and offer strategic guidance for manufacturers aiming to launch innovative vaccines in this dynamic environment. Download the piece to learn more: https://lnkd.in/e5qRNn5w #VaccineInnovation #HealthcareStrategy #VaccineLaunch #PublicHealth #PharmaInsights

Happy Holidays! Thank you to our clients, partners, and colleagues for an incredible year. Wishing you joy, warmth, and success in the year ahead! #HappyHolidays #ThankYou #NewYear2025

Early development is a critical phase for ensuring the success of your product. Addressing the right questions upfront can make all the difference in shaping its value and potential. Discover the key strategic questions you need to ask during early development to unlock the full potential in a product launch. Read the piece here: https://lnkd.in/dVRb3EfE #Biopharma #AssetDevelopment #StrategicPlanning #ProductLaunch #NavigateWithCertainty

The US vaccine landscape has transformed significantly since 2020, shaped by the pandemic, emerging technologies, and evolving priorities. In our latest white paper, explore these shifts, future trends, and strategic imperatives for manufacturers aiming to launch novel vaccines in this dynamic environment. Read the piece here: https://lnkd.in/eFvCmh4N Authors: Mariah Hanley, PhD, Principal Eric Auger, Partner, VPA Practice Lead Alexander Busch, Ph.D., Partner Scott Briggs, Partner #VaccineInnovation #HealthcareStrategy #VaccineLaunch #PublicHealth #PharmaInsights